Combined detection of GOLPH3, CEA, and CA19-9 may be used as a new diagnostic method and an index to evaluate the surgical effect after radical surgery, and GOLPH3 may be used as a novel tumor marker for GC and CRC. This evidence concerns the gene CEACAM5 and colorectal carcinoma.